menu
    • menu

    Company profile for Seres Therapeutics

    NEW Drugs in Dev: 9
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Seres Therapeutics is creating a new class of medicines using live bacteria to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seres TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Sidney Street Cambridge, MA 02139
    Telephone
    Telephone
    617-945-9626
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.serestherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/seres-health/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/serestx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Seres To Reduce Staff By 30% Amid Shift To Emerging Programs
    Seres To Reduce Staff By 30% Amid Shift To Emerging Programs

    13 Feb 2026

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    13 Feb 2026
    Share Share
    Seres Focuses On Emerging Inflammatory & Immune Disease Programs
    Seres Focuses On Emerging Inflammatory & Immune Disease Programs

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237063/0/en/Seres-Provides-Program-and-Corporate-Updates-and-Prioritizes-Emerging-Programs-in-Inflammatory-Immune-Diseases.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Seres Unveils Vowst's Mechanism in Top Journals
    Seres Unveils Vowst's Mechanism in Top Journals

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213447/0/en/Seres-Therapeutics-Announces-Publications-in-Nature-Medicine-and-Journal-of-Infectious-Diseases-Highlighting-Vowst-Mechanism-of-Action-and-Supporting-Broader-Live-Biotherapeutic-St.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Seres Therapeutics Joins Piper Sandler Healthcare Conference
    Seres Therapeutics Joins Piper Sandler Healthcare Conference

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193361/0/en/Seres-Therapeutics-to-Participate-in-Piper-Sandler-Healthcare-Conference.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Seres Therapeutics Unveils Q3 2025 Financials & Business
    Seres Therapeutics Unveils Q3 2025 Financials & Business

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181292/0/en/Seres-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Seres Therapeutics to Unveil Q3 2025 Financials Results
    Seres Therapeutics to Unveil Q3 2025 Financials Results

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177214/0/en/Seres-Therapeutics-to-Announce-Third-Quarter-2025-Financial-Results-and-Business-Updates-on-November-5-2025.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search